argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$947.52−3.43 (-0.36%)
Close on Nov 17, 2026Market cap –P/E 48.4Yield –
argenx market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
argenx's market cap was $61.14B on Nov 11, 2026, against $55.78B a year earlier. Over the last 5 years it ranged from $13.84B to $64.52B, with a median of $28.12B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $61.14B | +18.9% |
| 2025 | Dec 31, 2025 | $51.44B | +39.9% |
| 2024 | Dec 31, 2024 | $36.77B | +72.8% |
| 2023 | Dec 29, 2023 | $21.29B | +2.1% |
| 2022 | Dec 30, 2022 | $20.86B | +15.9% |
| 2021 | Dec 31, 2021 | $18.00B | +43.1% |
| 2020 | Dec 31, 2020 | $12.58B | +117.8% |
| 2019 | Dec 31, 2019 | $5.77B | +86.8% |
| 2018 | Dec 31, 2018 | $3.09B | +143.3% |
| 2017 | Dec 29, 2017 | $1.27B | – |
See a number that looks wrong?